Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/36367
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Galeano Jaramillo, Elkin de Jesús | - |
dc.contributor.author | Martínez Martínez, Alejandro | - |
dc.contributor.author | Rojas, Jhon J. | - |
dc.date.accessioned | 2023-08-25T16:22:10Z | - |
dc.date.available | 2023-08-25T16:22:10Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Galeano, E., Rojas, J. J., & Martínez, A. (2011). Pharmacological developments obtained from marine natural products and current pipeline perspective. Natural product communications, 6(2), 287–300. | spa |
dc.identifier.issn | 1934-578X | - |
dc.identifier.uri | https://hdl.handle.net/10495/36367 | - |
dc.description.abstract | ABSTRACT: Marine organisms represent a new extensive source for bioactive molecules. They have the potential to provide new therapeutic alternatives to treat human diseases. In this paper, we describe and discuss a variety of isolated and semisynthetic molecules obtained from marine phase II, phase III and at the commercialization stage of new drug development. A description of the mechanism of action, dosage used and side effects are also reported. The positive results obtained from these studies have triggered the development of new studies to evaluate the prospects for utilization of marine organisms. | spa |
dc.format.extent | 14 | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.publisher | SAGE Publications | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | spa |
dc.rights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/2.5/co/ | * |
dc.title | Pharmacological Developments Obtained from Marine Natural Products and Current Pipeline Perspectives | spa |
dc.type | info:eu-repo/semantics/article | spa |
dc.publisher.group | Productos Naturales Marinos | spa |
dc.identifier.doi | 10.1177/1934578X1100600233 | - |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 1555-9475 | - |
oaire.citationtitle | Natural product communications | spa |
oaire.citationstartpage | 287 | spa |
oaire.citationendpage | 300 | spa |
oaire.citationvolume | 6 | spa |
oaire.citationissue | 2 | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by-nc/4.0/ | spa |
dc.publisher.place | Westerville, Estados Unidos | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/ART | spa |
dc.type.local | Artículo de investigación | spa |
dc.subject.decs | Animales | - |
dc.subject.decs | Animals | - |
dc.subject.decs | Productos Biológicos - aislamiento y purificación | - |
dc.subject.decs | Biological Products - isolation y purification | - |
dc.subject.decs | Productos Biológicos - farmacología | - |
dc.subject.decs | Productos Biológicos - pharmacology | - |
dc.subject.decs | Descubrimiento de Drogas | - |
dc.subject.decs | Drug Discovery | - |
dc.subject.decs | Océanos y Mares | - |
dc.subject.decs | Oceans and Seas | - |
dc.description.researchgroupid | COL0015043 | spa |
dc.relation.ispartofjournalabbrev | Nat. Prod. Commun. | spa |
Aparece en las colecciones: | Artículos de Revista en Farmacéutica y Alimentarias |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
GaleanoElkin_2011_Pharmacological_Developments.pdf | Artículo de investigación | 424.18 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons